Blog: The Myriad gene patent case: its potential impact on the...
Aug 1, 2012 | Posted by: roboblogger | Full story: Mass High Tech
Recently, a federal appeals court heard oral arguments in a patent case, the ruling in which could significantly impact Massachusetts-based academic research organizations, biotechnology companies, and pharmaceutical companies.
9 Users are viewing the Biotech Forum right now
|Merck's MSD Pharma to create 800 jobs in India (Nov '08)||Dec 7||Jitendra Kumar Kushwaha||210|
|Obama announces $100 million initiative at Nati...||Dec 4||rajuarun||1|
|J&J Failed to Warn of Vaginal Mesh Risks, Jury ... (Mar '13)||Dec 2||jacobgabriel001||7|
|Verdict: $3.35 Million Awarded in Vaginal Mesh ... (Mar '13)||Dec 2||jacobgabriel001||3|
|U.S. Stock Futures Rise as Retail Sales Gain Mo... (Mar '13)||Dec 2||The Prudent Investor||5|
|Wockhardt receives Us Fda approval for cardiac ... (Oct '10)||Dec 1||Chitreana||15|
|Lawsuits filed over Lipitor side effects (Jun '06)||Nov 30||Mickey||801|